Stay Updated with the Latest Cheetah Mobile Inc. CMCM News in Real Time
Find CMCM news now at Meyka AI. Stay informed with the latest Cheetah Mobile Inc. stocks updates, including price news, market analysis, and expert insights.
Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions
Nike Inc chose the worst possible timing for a leadership change. Nike Inc (NYSE: NKE) announced on June 23, 2026, that CFO Matthew Friend will step down effective August 17, to be replaced by David M. Denton as incoming Chief Financial Officer. NKE traded near $45.20 as of June 15, already 44% below its 52-week…
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%. The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
Bharti Airtel (NSE: BHARTIARTL) Shares Turn Positive After Increasing Airtel Africa Stake to 79% in ₹28,200 Crore Deal
Bharti Airtel (NSE: BHARTIARTL) shares recovered and turned positive after the company’s landmark ₹28,200 crore Airtel Africa stake consolidation received near-unanimous shareholder approval on June 15, 2026. The deal raises Airtel’s indirect ownership in the Africa business from 62.73% to 79.04%. BHARTIARTL was trading around ₹1,910.80 recently, within a 52-week range of ₹1,740.50 to ₹2,174.50….
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Lloyds Banking Group PLC (LON: LLOY) Gains 0.048% as Lloyds Confirms 233 Branch Closures Across the UK
Lloyds Banking Group PLC (LON: LLOY) edged up 0.048% on June 23, 2026, trading at approximately 105.10p. The gain comes on the same day the group formally confirmed 233 branch closures in 2026, with another 12 sites set to follow in early 2027. The banking giant has now closed nearly 1,600 branches across the UK…
Comcast Outage Sparks Frustration Nationwide as System Update Knocks Services Offline
Millions of Americans rely on Comcast’s Xfinity network for internet, television, and communication services. On June 22, 2026, many customers suddenly lost access to key services as a widespread Comcast Outage impacted users across the United States. The disruption triggered thousands of complaints on outage tracking platforms and social media, with customers reporting problems accessing…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…